DE3783024D1 - Topische ofloxacin enthaltende zubereitung. - Google Patents

Topische ofloxacin enthaltende zubereitung.

Info

Publication number
DE3783024D1
DE3783024D1 DE8787118844T DE3783024T DE3783024D1 DE 3783024 D1 DE3783024 D1 DE 3783024D1 DE 8787118844 T DE8787118844 T DE 8787118844T DE 3783024 T DE3783024 T DE 3783024T DE 3783024 D1 DE3783024 D1 DE 3783024D1
Authority
DE
Germany
Prior art keywords
preparation containing
containing topical
ofloxacin
methyl
topical ofloxacin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787118844T
Other languages
English (en)
Other versions
DE3783024T2 (de
Inventor
Sadao C O Daiichi Seiya Hirota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17908606&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3783024(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3783024D1 publication Critical patent/DE3783024D1/de
Publication of DE3783024T2 publication Critical patent/DE3783024T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE8787118844T 1986-12-18 1987-12-18 Topische ofloxacin enthaltende zubereitung. Expired - Lifetime DE3783024T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61302412A JP2558107B2 (ja) 1986-12-18 1986-12-18 外用剤

Publications (2)

Publication Number Publication Date
DE3783024D1 true DE3783024D1 (de) 1993-01-21
DE3783024T2 DE3783024T2 (de) 1993-04-15

Family

ID=17908606

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787118844T Expired - Lifetime DE3783024T2 (de) 1986-12-18 1987-12-18 Topische ofloxacin enthaltende zubereitung.

Country Status (10)

Country Link
US (1) US4923862A (de)
EP (1) EP0274714B1 (de)
JP (1) JP2558107B2 (de)
KR (1) KR950010152B1 (de)
AT (1) ATE83148T1 (de)
CA (1) CA1309025C (de)
DE (1) DE3783024T2 (de)
ES (1) ES2042534T3 (de)
GR (1) GR3006426T3 (de)
PH (1) PH26546A (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3881939T2 (de) * 1987-02-26 1993-09-30 Rohto Pharma Verwendung von Ofloxacin zur lokalen Behandlung oder Prophylaxe von Beschwerden der Wurzelhaut der Zähne.
JPH01258620A (ja) * 1988-04-08 1989-10-16 Dai Ichi Seiyaku Co Ltd 耳疾患用局所製剤
US5681812A (en) * 1991-12-10 1997-10-28 Rush Presbyterian-St. Luke's Medical Center Methods and compositions for reducing multidrug resistance
AU3243393A (en) * 1991-12-10 1993-07-19 Rush - Presbyterian - St. Luke's Medical Center Methods and compositions for reducing multi-drug resistance
US5686095A (en) * 1995-10-23 1997-11-11 Price, Jr.; Francis W. Method of treating canker sores
DE19729879C2 (de) 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
US6248343B1 (en) 1998-01-20 2001-06-19 Ethicon, Inc. Therapeutic antimicrobial compositions
US6022551A (en) * 1998-01-20 2000-02-08 Ethicon, Inc. Antimicrobial composition
US5972358A (en) * 1998-01-20 1999-10-26 Ethicon, Inc. Low tack lotion, gels and creams
US5997893A (en) * 1998-01-20 1999-12-07 Ethicon, Inc. Alcohol based anti-microbial compositions with cosmetic appearance
MY122454A (en) * 1998-06-05 2006-04-29 Upjohn Co Use of oxazolidinones for the preparation of a medicament for transdermal delivery
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
US7439271B2 (en) * 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
JP2003192773A (ja) * 2001-12-26 2003-07-09 Mitsui Chemicals Inc 生体吸収性ポリヒドロキシカルボン酸及びその製造法
DE10351644A1 (de) * 2003-11-05 2005-06-09 Bayer Technology Services Gmbh Verfahren zur Herstellung von lagerstabilen multiplen Emulsionen
US10617703B2 (en) * 2014-12-10 2020-04-14 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US10898491B2 (en) * 2015-12-18 2021-01-26 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5576875A (en) * 1978-08-31 1980-06-10 Otsuka Pharmaceut Co Ltd Benzo ij quinolizine-2-carboxylic acid derivative and its preparation
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4551456A (en) * 1983-11-14 1985-11-05 Merck & Co., Inc. Ophthalmic use of norfloxacin and related antibiotics
JPS6333329A (ja) * 1986-07-28 1988-02-13 Michio Nakanishi 抗菌剤含有組成物

Also Published As

Publication number Publication date
DE3783024T2 (de) 1993-04-15
KR950010152B1 (ko) 1995-09-11
KR880007076A (ko) 1988-08-26
GR3006426T3 (de) 1993-06-21
JP2558107B2 (ja) 1996-11-27
ATE83148T1 (de) 1992-12-15
PH26546A (en) 1992-08-19
ES2042534T3 (es) 1993-12-16
EP0274714A1 (de) 1988-07-20
EP0274714B1 (de) 1992-12-09
CA1309025C (en) 1992-10-20
US4923862A (en) 1990-05-08
JPS63154621A (ja) 1988-06-27

Similar Documents

Publication Publication Date Title
DE3783024D1 (de) Topische ofloxacin enthaltende zubereitung.
NO2002009I2 (no) Tiotropium
EP0245518A4 (de) Isoflavon-abkömmlinge, salze dazu sowie onkostatische und immunsuppressive mittel.
DE3575924D1 (de) Substituierte 9-fluor-3-methyl-7-oxo-2,3-dihydro-7h-pyrido(1,2,3-de)(1,4)benzoxazin-6-carbonsaeure
NL187314C (nl) Antibacterieel preparaat, alsmede een op plaats 1 gesubstitueerd 7-(3-aminopyrrolidino)-6-fluor-4-oxo-1,4-dihydro-1,8-naftyridine-3-carbonzuur derivaat.
AU590055B2 (en) N-substituted-6-fluoro-7-(substituted-N-piperazino or pyrrolidino)-8-substituted-4-oxo-1,4dihydro-quinoline-3- carboxylic acid derivatives
DE3888897D1 (de) Imidazo[1,2-b]pyridazinderivate.
NO163856C (no) Fremgangsmaate til fremstilling av ikke-toksiske salter av6-metyl-3,4-dihydro-1,2,3-oksatiazin-4-on-2,2-dioksyd.
DE3664910D1 (de) Substituted 2,3,4,9-tetrahydro-1h-carbazole-1-acetic acid derivatives
DE68913498T2 (de) 1,1-dioxo-cephem-4-carbothiolsäure-derivate.
AU7317287A (en) 5,6,8-triflouro-quinol-4-one-3-carboxylic acid derivatives
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
AU585129B2 (en) N-tridecyl-2,6-dimethyl-morpholine fluoboric acid salt
DK0579939T3 (da) Phospholipidderivater
IS1559B (is) Nýjar 16,17 asetalsúbstitúeraðar pregnan-21-karboxýlsýruafleiður
ES2023410B3 (es) Acidos 1,3,4,9-tetrahidropiran 3,4-b]indol -1 aceticos sustituidos.
ITMI911577A1 (it) Procedimento per la preparazione dell'acido 9-fluoro-10- (4-metil-1-piperazinil)-7-oxo-2, 3-diidro-7h-pirido (1, 2, 3-de) (1, 4)benzotiadin-6-carbossilico cloridrato.
NO863094D0 (no) Fremgangsmaate for fremstilling av 5-klor-s-triazolo-(4,3-a)-pyridin-7-carboxylsyrer.
NO880088D0 (no) 2,1-benzotiazepin-2,2-dioksyd-5-karboksylsyrederivater.
DE3367216D1 (de) 3-deazaguanine sulphonic acid salts
LV5739B4 (lv) 1-Azatriciklo[7.2.03,8]undec-2-en-2-karbonskabes atvasinajumi
DE3668890D1 (de) 3,4-dihydro-4-oxo-2h-1-benzopyranyloxy-alkansaeure-derivate.
FI882515A0 (fi) Foerfarande foer framstaellning av antibakteriskt aktiva 8-amino-9-fluor-3-metyl-7-oxo-2,3-dihydro-7h -pyrido (1,2,3-de) (1,4) benzoxazin-6-karboxylsyrederivat.
LV5737B4 (lv) Tetrahidro-1H-pirido[4,3-B]indol-1-ona atvasinajumi
ATE102207T1 (de) 1,1-dioxo-cephem-4-carbothiolsaeure-derivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition